Companies · Other Health Care

Susquehanna Lithortripsy Llc

Nanticoke · Other Health Care

Diligence memoA one-page analyst read on Susquehanna Lithortripsy Llc — recommendation, valuation, rhythm, risks.
$916K
Total raised · real
2
Rounds
0.2×
Latest step-up
Top 70%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Tue Jul 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Susquehanna Lithortripsy Llc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.44× the median modeled value of Pre-Seed Other Health Care companies in 2016–2018 (299 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.9 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Susquehanna Lithortripsy Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
13.0 yr record
Peak capital year was 2013 with $763K across 1 filings.
Market position
ahead of 31% of Other Health Care peers
Capital scale is ahead of 31% of Other Health Care peers; modeled value is above 20% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2013: $763K across 1 filings.
  • Largest single filing was $763K on 2013-07-01.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Susquehanna Lithortripsy Llc is one of 5377 Other Health Care companies tracked from Nanticoke. By capital raised it ranks in the long tail (ahead of 31% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 504
Reg D exemption
1
Investors (latest)
2018-07-24
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MPre-Seed · 2013-07-01 Raised $763K (real) Modeled valuation $24M (est)$763K$24MPre-Seed2013Pre-Seed · 2018-07-24 Raised $153K (real) Modeled valuation $4.7M (est)$153K$4.7MPre-Seed2018+$153KCumulative $916K

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$763K · 2013
Pre-Seed extension$153K · 2018

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$4.7M
Base estimate est.
$96K
Conservative case
$53.3M
Upside case
$848K
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $23.5M · 2013-07-012013Pre-Seed · modeled $4.7M · 2018-07-242018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
28%
Survival probability
11% low · 52% high
1.64×/yr
Annual markup
2.23×/yr upside case
6.0 yr
Elapsed time used
7.9 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
61 mo
Avg between rounds
$181K/yr
Capital velocity
13.0 yr
On record since
2013
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.4× of median
This company$916K
Sector median$2.4M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 0.4× of median
This company$153K
Sector median$350K
Modeled value — vs sector median (estimate, all stages) 0.2× of median
This company$4.7M
Sector median$22.1M

Raised more than 31% of sector peers (real $). Modeled value above 20% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #249 of 299.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)PortCo, LP · Pre-Seed Raised $1.0M · modeled $30.8M (est)Brogent International LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)ShiftWizard, Inc. · Pre-Seed Raised $2.8M · modeled $30.8M (est)Audio Bionics International Inc. · Pre-Seed Raised $2.9M · modeled $30.8M (est)USRC East Dallas, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Chartered Medical Solutions LP · Pre-Seed Raised $2.0M · modeled $30.8M (est)CRG Medical, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)iOrthopedics, Inc. · Pre-Seed Raised $1.0M · modeled $30.8M (est)USRC West Fork, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)AHC of Henderson, LLC · Pre-Seed Raised $1.0M · modeled $30.8M (est)Orthoevidence Inc. · Pre-Seed Raised $1.1M · modeled $30.8M (est)VivaQuant, LLC · Pre-Seed Raised $1.2M · modeled $30.8M (est)Susquehanna Lithortripsy Llc (this company) Raised $916K · modeled $4.7M (est)Susquehanna Lithortripsy Llc
CompanyStageRaised · realValue · estvs peer med.
PortCo, LPPre-Seed$1.0M$30.8M2.86×
Brogent International LLCPre-Seed$1.0M$30.8M2.86×
ShiftWizard, Inc.Pre-Seed$2.8M$30.8M2.86×
Audio Bionics International Inc.Pre-Seed$2.9M$30.8M2.86×
USRC East Dallas, LLCPre-Seed$1.0M$30.8M2.86×
Chartered Medical Solutions LPPre-Seed$2.0M$30.8M2.86×
CRG Medical, Inc.Pre-Seed$1.0M$30.8M2.86×
iOrthopedics, Inc.Pre-Seed$1.0M$30.8M2.86×
USRC West Fork, LLCPre-Seed$1.0M$30.8M2.86×
AHC of Henderson, LLCPre-Seed$1.0M$30.8M2.86×
Orthoevidence Inc.Pre-Seed$1.1M$30.8M2.86×
VivaQuant, LLCPre-Seed$1.2M$30.8M2.86×
Susquehanna Lithortripsy Llc this companyPre-Seed$916K$4.7M0.44×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$763K2013-07-01$4.2M$23.5M85%
Pre-Seed$153K2018-07-24$848K$4.7M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$763K2013-07-01
    • First recorded raise — entered as Pre-Seed.
  2. Pre-Seed$153K2018-07-24
    • Raised again after 61 mo — slower than the ~14 mo sector norm.
    • Round 5.0× smaller than the prior — bridge or down round.
    • Switched to Rule 504 (was Rule 506(b)).
    • 1 investor on this round.
Intelligence
2023 ~Q3
Modeled next raise · ~61mo cadence
$153K
Modeled next size est.range $153K$244K
0.2×
Last step-up
$181K/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Alan Buergenthal11 other2018-07
Charles Dalton2013-07
Charles Zaleski2013-07
Charles Zaleski, M. D.2018-07
Glenn Bloiso2013-07
Glenn Bloiso, M.D.2018-07
Henry, II Wise2013-07
Howard Miller, M.D.2018-07
Scott Niditch2013-07
Scott Niditch, M.D.2018-07
Steven Rockoff2013-07
Steven Rockoff, M.D.2018-07
Registry & provenance

Susquehanna Lithortripsy Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1112615
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Harrisburg Lithotripsy LLCOther Health CarePre-Seed$912K$1.2Mnetwork1 shared operator · same sector · same stage
Greater Michigan Lithotripsy, LLCOther Health CarePre-Seed$925K$3.0Mnetwork1 shared operator · same sector · same stage
Urolith, LLCOther Health CarePre-Seed$880K$1.4Mnetwork1 shared operator · same sector · same stage
Kidney Stone Associates, LlcOther Health CarePre-Seed$845K$13.8Mnetwork1 shared operator · same sector · same stage
Atlantic Lithotripsy, LlcOther Health CarePre-Seed$1.5M$4.7Mnetwork1 shared operator · same sector · same stage
SWL Therapies LLCOther Health CarePre-Seed$383K$3.3Mnetwork1 shared operator · same sector · same stage
SWL Therapies II, LLCOther Health CarePre-Seed$140K$4.3Mnetwork1 shared operator · same sector · same stage
PP6 Madison, LLCOther Health CarePre-Seed$915K$5.1Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Wisconsin Lithotripsy, LLCOther Health CarePre-Seed$5.9M87%
Pontchartrain Lithotripsy, LLCOther Health CarePre-Seed$6.3M85%
Dfw Lithotripsy LlpOther Health CarePre-Seed$9.6M85%
Dothan Lithotripsy, LLCOther Health CarePre-Seed$339K84%
LithoOne, LLCOther Health CarePre-Seed$6.4M84%
Diamond State Lithotripsy, LLCOther Health CarePre-Seed$3.5M83%
Maritime Lithotripsy LlcOther Health CarePre-Seed$10.6M83%
Plymouth Rock Lithotripsy, LLCOther Health CarePre-Seed$3.3M83%
Frequently asked
How much funding has Susquehanna Lithortripsy Llc raised?
Susquehanna Lithortripsy Llc has raised approximately $916K in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Susquehanna Lithortripsy Llc's estimated valuation?
Provath's modeled valuation for Susquehanna Lithortripsy Llc is approximately $4.7M (modeled range $96K–$53.3M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Susquehanna Lithortripsy Llc at?
Susquehanna Lithortripsy Llc's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Tue Jul 24.
What does Susquehanna Lithortripsy Llc do and where is it based?
Susquehanna Lithortripsy Llc operates in the Other Health Care sector, based in Nanticoke.
Explore related

See where Susquehanna Lithortripsy Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Susquehanna Lithortripsy Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.